FIELD: veterinary medicine.
SUBSTANCE: method involves determining protein expression level induced during pregnancy in an animal with desirable pregnancy status. Protein expression level of this animal is compared to the protein expression level in non-pregnant animals.
EFFECT: high accuracy and reproducibility of pregnancy test.
36 cl, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT KNOCKOUT MUTANT OF NODULAR DERMATITIS VIRUS AND ITS APPLICATION | 2016 |
|
RU2697151C2 |
| TRANSGENIC HOOFED ANIMALS, HAVING LOWER ACTIVITY OF PRION PROTEIN, AND THEIR APPLICATIONS | 2003 |
|
RU2384059C2 |
| METHOD FOR OBTAINING ANIMAL EMBRYOS AND METHOD FOR RAISING ANIMALS OUT OF EMBRYOS | 1998 |
|
RU2216592C2 |
| METHOD OF STIMULATING IMMUNE RESPONSE AGAINST ANIMAL PARASITIC HELMINTHS | 1994 |
|
RU2145876C1 |
| METHOD OF IMPROVING REPRODUCTIVE FUNCTION IN FEMALES OF RUMINANT MAMMALS | 2005 |
|
RU2404579C2 |
| METHOD FOR PRODUCTION OF TRANSGENIC RABBITS PRODUCING PROTEINS INTO MAMMARY GLAND | 2007 |
|
RU2402211C2 |
| METHOD OF TRANSGENIC SHEEP PRODUCING | 1987 |
|
RU2085587C1 |
| ISOLATED NUCLEIC ACID ENCODING FELINE LIGAND CD86, DIAGNOSTIC OLIGONUCLEOTIDE, CLONING VECTOR, VACCINE, METHODS FOR INDUCTION OR SUPPRESSION OF IMMUNITY IN CAT | 1999 |
|
RU2263145C2 |
| RECOMBINANT VACCINES AGAINST BLUETONGUE VIRUS, THEIR USE | 2011 |
|
RU2575599C2 |
| DETERMINATION OF DOSE FOR IMMUNOTHERAPEUTIC AGENTS | 2017 |
|
RU2771717C2 |
